LexDanaLexDanabeta
Inventor

RAVI SALGIA

Inventor
US

Overview

3→
Patents
2022–2023
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds14%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms14%
G01NInvestigating or analysing materials by determining their chemical or physical properties14%
PatentTitleYear
11,672,812Methods and compositions comprising tyrosine kinase inhibitor and triptolide for the treatment of cancer202311,390,922C-CBL mutations and uses thereof202211,213,510Thioindirubins2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2023Patents assigned to HOPE CITY (2)· patent assignee history
2022Patents assigned to NATIONAL AND KAPODISTRIAN UNIV OF ATHENS (1)· patent assignee history
2022Patents assigned to UNIV CHICAGO (1)· patent assignee history
2022–2023Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
HOPE CITY22022–2023
NATIONAL AND KAPODISTRIAN UNIV OF ATHENS12022
UNIV CHICAGO12022
Locations
LocationPatentsSpan
US32022–2023